hoe 694 has been researched along with Hyperlipoproteinemia Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assmann, G; Kehrel, B; Nofer, JR; Seedorf, U; Tepel, M; Walter, M; Wierwille, S; Zidek, W | 1 |
1 other study(ies) available for hoe 694 and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
Topics: Adult; Antigens, CD; Binding Sites; Blood Platelets; Guanidines; Humans; Hydrogen-Ion Concentration; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Oxidation-Reduction; P-Selectin; Phosphatidylinositols; Platelet Aggregation; Platelet Membrane Glycoproteins; Propionates; Prostaglandins; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetraspanin 30; Thrombin; Type C Phospholipases | 1997 |